Brief: Argenx Reports $1.3 Billion In Q4 Global Product Net Sales
26/02/2026 06:11
Feb 26 (Reuters) - argenx SE ARGX.BR: ARGENX REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES FOURTH QUARTER BUSINESS UPDATE $1.3 BILLION IN FOURTH QUARTER AND $4.2 BILLION IN FULL YEAR GLOBAL PRODUCT NET SALES, DELIVERED $1.1 BILLION IN OPERATING INCOME IN 2025 Source text: ID:nGNE5qk1Fd Further company coverage: ARGX.BR (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles